We are advising Clarivate on the transaction

Davis Polk is advising Clarivate Plc on the sale of its Life Sciences & Healthcare segment to Altaris LLC for a headline value of $600 million. The transaction is expected to close by the end of 2026, subject to customary closing conditions, including regulatory approvals.

Clarivate is a leading global provider of transformative intelligence. Following the transaction, the company will be a subscription-first provider of intelligence solutions, workflow software and tech-enabled services focused on its Academia & Government and Intellectual Property segments.

Altaris is an investment firm focused exclusively on acquiring and building companies in the healthcare industry.

The Davis Polk corporate team includes partner Daniel Brass, counsel Saagar Kaul and associates Jonathan Bi and Costa Theodore. Partner Frank Azzopardi and associate Lachlan J. Forrester are providing intellectual property and commercial transactions advice. Partners Michael Mollerus and Dominic Foulkes are providing tax advice. Partner Jack Orford is providing sponsor finance advice. Partner Kyoko Takahashi Lin is providing executive compensation advice. Members of the Davis Polk team are based in the New York and London offices.

Copy link to share post